[EN] PRODRUGS OF FUSED-BICYCLIC C5aR ANTAGONISTS<br/>[FR] PROMÉDICAMENTS D'ANTAGONISTES DE C5AR BICYCLIQUES FUSIONNÉS
申请人:CHEMOCENTRYX INC
公开号:WO2019195159A1
公开(公告)日:2019-10-10
The present disclosure provides, inter alia, Compounds of Formulae IA, IB, IC, IIA, IIB and IIC or pharmaceutically acceptable salts thereof that are modulators of the C5a receptor. Also provided are pharmaceutical compositions and methods of use including the treatment of diseases or disorders involving pathologic activation from C5a and non-pharmaceutical applications.